Site Search
Search Results
New York Biomarker Testing Campaign
Welcome! Precision medicine is changing the way we treat cancer. Biomarker testing is the key to unlocking access to these personalized treatments. ACS CAN and partners are working together to make sure more New Yorkers have access to the right medicine at the right time. Ask Governor Hochul to Sign the New York Biomarker Bill Without Delay Please send a message to Governor Hochul today and implore her to sign our bill the minute it hits her desk! New ...
Biomarker Testing Is The Key To Precision Medicine
Precision medicine is changing the way we treat cancer and biomarker testing is the key to opening the door to the types of personalized cancer treatments that can improve survival rates and quality of life. A.1673 and S.1196 requires all state-regulated insurance plans, including Medicaid, to cover biomarker testing when medically appropriate. Read other patients who have benefited from biomarker testing in the New York Biomarker Testing ...
New York State Senate Votes to Remove Barriers to Biomarker Testing
ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. This legislative victory came several hours after the ... Cancer Society Cancer Action Network (ACS CAN) hosted cancer patients and survivors at the Capitol to honor National Cancer Survivors Day. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, ...
Health Care Providers Call on Governor Hochul to Sign Biomarker Testing Bill without Delay
... gathered today at the Northwell Health Cancer Institute to call on Governor Kathy Hochul to prioritize health equity by improving access to biomarker testing and signing Senate Bill 1196a / Assembly Bill 1673a into law. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...
Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing
... and cancer survivors from across New York will gather at the Capitol building on Wednesday, May 17 to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673, which aim to improve New Yorkers’ access to biomarker testing – a tool that opens the door to precision medicine. WHAT: Improving Access to Biomarker Testing: Opportunity to ...
Advocates Call for Senate Vote on Biomarker Testing Legislation, Citing Importance of Precision Medicine in Innovation
... lawmakers to support legislation that can improve access to clinical trials. Senate Bill 1196 / Assembly Bill 1673 seek to eliminate barriers to biomarker testing, which is increasingly critical to the participation in and development of clinical trials. Clinical trials are critical to medical ... potential new cancer treatments from the research setting to the cancer care clinic. Increasingly, cancer clinical trials are driven by biomarker testing and the development of targeted therapies. Patients’ biomarker testing results help to identify whether they might be eligible ...
Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support
... 17, 2023 – Earlier today, oncologists and cancer survivors from across New York gathered at the Capitol to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673. This legislation, which is being sponsored by Asm. Pamela Hunter and Sen. Roxanne Persaud and maintains bipartisan support, aims to improve New Yorkers’ access to precision medicine through biomarker testing. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that ...
Cancer Survivors Rally for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Bill
... today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on ... 1673a and reject any attempts to weaken the bill by limiting its scope. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
... Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign Senate Bill 1196a / Assembly Bill 1673a and reject any attempts to weaken the bill by limiting its scope. Biomarker testing enables physicians to match patients with personalized care and improve patient quality of life by avoiding ineffective, invasive ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
... seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine. Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. ...